Benzinga | Aug 9, 2021 04:59PM EDT

Paratek Pharmaceuticals Q2 EPS $0.20 Misses $0.31 Estimate, Sales $57.49M Miss $60.99M Estimate

Paratek Pharmaceuticals (NASDAQ:PRTK) reported quarterly earnings of $0.20 per share which missed the analyst consensus estimate of $0.31 by 35.48 percent. This is a 137.74 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $57.49 million which missed the analyst consensus estimate of $60.99 million by 5.74 percent. This is a 516.47 percent increase over sales of $9.33 million the same period last year.